COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,551 Articles (22,400 medRxiv, 8,151 bioRxiv)

Most recent first Previous |  Page 703: Articles 7021-7030  | Next

Omicron and vaccines: An analysis on the decline in COVID-19 mortality
Larrauri, B., Malbran, A., Larrauri, J. A.
10.1101/2022.05.20.22275396 — Posted: 2022-05-23
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform
Zheng, B., Green, A. C., Tazare, J., Curtis, H. J., Fisher, L., Nab, L., Schultze, A., Mahalingasivam, V., Parker, E., Hulme, W. J., Bacon, S. C., DeVito, N. J., Bates, C., Evans, D., Inglesby, P., Drysdale, H., Davy, S., Cockburn, J., Morton, C. E., Hickman, G., Ward, T., Smith, R. M., Parry, J., Hester, F., Harper, S., Mehrkar, A., Eggo, R. M., Walker, A. J., Evans, S. J., Douglas, I. J., MacKenna, B., Goldacre, B., Tomlinson, L. A.
10.1101/2022.05.22.22275417 — Posted: 2022-05-23
Social divisions and risk perception can drive divergent epidemic dynamics and large second and third waves
Harris, M. J., Mordecai, E. A.
10.1101/2022.05.20.22275407 — Posted: 2022-05-23
Assessment of subtle cognitive impairments in patients with post-COVID syndrome with the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus).
Kozik, V., Reuken, P., Utech, I., Gramlich, J., Stallmach, Z., Demeyere, N., Stallmach, A., Finke, K.
10.1101/2022.05.23.22275442 — Posted: 2022-05-23
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors
Cheetham, N. J., Kibble, M., Wong, A., Silverwood, R. J., Knuppel, A., Williams, D. M., Hamilton, O. K. L., Lee, P. H., Bridger Staatz, C., Di Gessa, G., Zhu, J., Katikireddi, S. V., Ploubidis, G. B., Thompson, E. J., Bowyer, R. C. E., Zhang, X., Abbasian, G., Garcia, M. P., Hart, D., Seow, J., Graham, C., Kouphou, N., Acors, S., Malim, M. H., Mitchell, R. E., Northstone, K., Major-Smith, D., Matthews, S., Breeze, T., Crawford, M., Molloy, L., Kwong, A. S. F., Doores, K. J., Chaturvedi, N., Duncan, E. L., Timpson, N. J., Steves, C. J.
10.1101/2022.05.19.22275214 — Posted: 2022-05-22
Assessing the knowledge and practices of primary healthcare workers on malaria diagnosis and related challenges in view of COVID-19 outbreak in a Nigerian Southwestern Metropolis
Ayandipo, O. E., Babatunde, D., Afolayan, O., Kalejaye, O., Obembe, T.
10.1101/2022.05.20.22275356 — Posted: 2022-05-22
SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma, Delta, and Omicron coincident with consecutive pandemic waves in Pakistan
Nasir, A., Aamir, U. B., Kanji, A., Samreen, A., Ansar, Z., Ghanchi, N., Bukhari, A. R., Masood, K. I., Islam, N., Ghanic, S., Syed, M. A., Wassan, M., Mahmood, S. F., Hasan, Z.
10.1101/2022.05.19.22275149 — Posted: 2022-05-22
Understanding Post-Acute Sequelae of SARS-CoV-2 Infection through Data-Driven Analysis with the Longitudinal Electronic Health Records: Findings from the RECOVER Initiative
Zang, C., Zhang, Y., Xu, J., Bian, J., Morozyuk, D., Schenck, E. J., Khullar, D., Nordvig, A. S., Shenkman, E. A., Rothman, R. L., Block, J. P., Lyman, K., Weiner, M., Carton, T. W., Wang, F., Kaushal, R.
10.1101/2022.05.21.22275420 — Posted: 2022-05-22
Association of results of four lateral flow antibody tests with subsequent SARS-CoV-2 infection
Findlater, L., Trickey, A., Jones, H., Trindall, A., Taylor-Phillips, S., Mulchandani, R., EDSAB-HOME investigators, , Oliver, I., Wyllie, D.
10.1101/2022.05.19.22275126 — Posted: 2022-05-22
Emergence of a Pseudomonas aeruginosa Hypermutator Strain During the Course of Ventilator-Associated Pneumonia
Nozick, S., Ozer, E. A., Kumar, R., Mills, J., Wunderink, R. G., Qi, C., Hauser, A.
10.1101/2022.05.19.22275029 — Posted: 2022-05-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).